SECsense Logo

Citius Pharmaceuticals, Inc. Form 8-K Report Overview - December 2024

$CTXR
Form 8-K
Filed on: 2024-12-27
Source
Citius Pharmaceuticals, Inc. Form 8-K Report Overview - December 2024

Here is the key information extracted from the provided section of the financial report:

  1. Company Information:
  • Name: Citius Pharmaceuticals, Inc.
  • CIK: 0001506251
  • Ticker Symbol: CTXR
  • Exchange: NASDAQ
  • Address: 11 Commerce Drive, 1st Floor, Cranford, NJ 07016
  • Phone: 908-967-6677
  1. Filing Details:
  • Filing Type: Form 8-K
  • Filing Date: December 27, 2024
  1. Financial Metrics:
  • Common Stock: Par value of $0.001
  • Measurement Units:
    • Currency: USD (United States Dollar)
    • Shares: Standard measure for equity shares
    • USD per Share: Indicates a financial metric that likely relates to the price or valuation of the common stock.
  1. Context Information:
  • Period Context: The report is based on data as of December 27, 2024.

This section primarily provides a snapshot of Citius Pharmaceuticals, Inc., including key identifiers, the type of filing, and basic share and monetary information. Further insights would be drawn from additional sections of the financial report that would detail performance metrics, financial statements, and management commentary.